Download: Interview with China’s Ministry of Health on Chinese orphan drug market access


orphan drug market access in china One of China’s recent healthcare reform priorities is to expand the list of critical diseases covered by the rural health cooperative medical care systems.

Vice President Li Keqiang mentioned in a meeting with the health care reform committee under the State Council that the types of critical illnesses covered by insurance will continue to expand and the percentage of reimbursement provided by government will also continue to increase.

In light of this, we interviewed Ping Guo, Vice President of Beijing YuanTang Institute of Gene Science, part of China’s Ministry of Health. The transcript of his interview is included in this document.

Download the interview transcript here for insights on market access in China for orphan drugs.

Questions addressed include:

  • What commitment is the government making to provide orphan drugs to treat critical illnesses?
  • How can orphan drug companies help support the Chinese government ‘s initiatives?
  • How will providers be educated and trained to understand previously untreatable conditions? How will they be encouraged to diagnose and treat rare disease patients?
  • What are some good first steps for companies who seek to partner with the Chinese government to bring orphan drugs to market?

Get your copy of the interview now!

Ping Guo will be speaking at the upcoming World Orphan Drug Congress USA on this topic.




We welcome a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s